Search

Anne Marie Falk

Examiner (ID: 7004)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
685
Issued Applications
242
Pending Applications
153
Abandoned Applications
292

Applications

Application numberTitle of the applicationFiling DateStatus
09/581308 Therapeutic use of lentiviral vectors Feb 8, 2001 Abandoned
Array ( [id] => 6099318 [patent_doc_number] => 20020053093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Methods of assaying receptor activity and constructs useful in such methods' [patent_app_type] => new [patent_app_number] => 09/772644 [patent_app_country] => US [patent_app_date] => 2001-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18078 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20020053093.pdf [firstpage_image] =>[orig_patent_app_number] => 09772644 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/772644
Methods of assaying receptor activity and constructs useful in such methods Jan 29, 2001 Issued
Array ( [id] => 6294878 [patent_doc_number] => 20020056144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening)' [patent_app_type] => new [patent_app_number] => 09/772503 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26091 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20020056144.pdf [firstpage_image] =>[orig_patent_app_number] => 09772503 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/772503
Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening) Jan 28, 2001 Abandoned
Array ( [id] => 6020482 [patent_doc_number] => 20020104110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Immunologically privileged cells and uses thereof' [patent_app_type] => new [patent_app_number] => 09/770601 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18105 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20020104110.pdf [firstpage_image] =>[orig_patent_app_number] => 09770601 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/770601
Immunologically privileged cells and uses thereof Jan 25, 2001 Issued
Array ( [id] => 6927753 [patent_doc_number] => 20050241010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Method for functional mapping of an alzheimer\'s disease gene network and for identifying therapeutic agents for the treatment of alzheimer\' s disease' [patent_app_type] => utility [patent_app_number] => 10/182087 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16232 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20050241010.pdf [firstpage_image] =>[orig_patent_app_number] => 10182087 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/182087
Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer' s disease Jan 22, 2001 Abandoned
Array ( [id] => 5803708 [patent_doc_number] => 20020010947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Transgenic mouse model of human neurodegenerative disease' [patent_app_type] => new [patent_app_number] => 09/767088 [patent_app_country] => US [patent_app_date] => 2001-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6801 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010947.pdf [firstpage_image] =>[orig_patent_app_number] => 09767088 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/767088
Transgenic mouse model of human neurodegenerative disease Jan 21, 2001 Abandoned
Array ( [id] => 33082 [patent_doc_number] => 07785882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them' [patent_app_type] => utility [patent_app_number] => 10/181329 [patent_app_country] => US [patent_app_date] => 2001-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 41 [patent_no_of_words] => 10419 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785882.pdf [firstpage_image] =>[orig_patent_app_number] => 10181329 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/181329
Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them Jan 17, 2001 Issued
09/750456 Novel mutated mammalian cells and animals Dec 27, 2000 Abandoned
Array ( [id] => 5987367 [patent_doc_number] => 20020099025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Treatment of neurological disorders' [patent_app_type] => new [patent_app_number] => 09/748657 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13077 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099025.pdf [firstpage_image] =>[orig_patent_app_number] => 09748657 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/748657
Treatment of neurological disorders Dec 21, 2000 Abandoned
09/623565 Identification of pactolus: a beta integrin-like protein Dec 11, 2000 Abandoned
Array ( [id] => 6797792 [patent_doc_number] => 20030176666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Hypothalamus-specific polypeptides\n' [patent_app_type] => new [patent_app_number] => 09/735138 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25814 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176666.pdf [firstpage_image] =>[orig_patent_app_number] => 09735138 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/735138
Hypothalamus-specific polypeptidesn Dec 11, 2000 Abandoned
Array ( [id] => 6948063 [patent_doc_number] => 20010021699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Therapeutic and drug screening methods for the treatment and prevention of neuronal disease' [patent_app_type] => new [patent_app_number] => 09/735066 [patent_app_country] => US [patent_app_date] => 2001-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21653 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021699.pdf [firstpage_image] =>[orig_patent_app_number] => 09735066 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/735066
Methods for enhancing survival of a neuron Dec 10, 2000 Issued
Array ( [id] => 6851534 [patent_doc_number] => 20030143737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Long-term cell-culture compositions and genetically modified animals derived therefrom' [patent_app_type] => new [patent_app_number] => 09/732520 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 9661 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143737.pdf [firstpage_image] =>[orig_patent_app_number] => 09732520 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/732520
Long-term cell-culture compositions and genetically modified animals derived therefrom Dec 6, 2000 Abandoned
Array ( [id] => 1235491 [patent_doc_number] => 06689610 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same' [patent_app_type] => B1 [patent_app_number] => 09/724962 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 15295 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689610.pdf [firstpage_image] =>[orig_patent_app_number] => 09724962 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/724962
Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same Nov 27, 2000 Issued
09/701156 Gene expression method Nov 21, 2000 Abandoned
Array ( [id] => 919968 [patent_doc_number] => 07321074 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-01-22 [patent_title] => 'Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight' [patent_app_type] => utility [patent_app_number] => 10/129599 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 47 [patent_no_of_words] => 21522 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/321/07321074.pdf [firstpage_image] =>[orig_patent_app_number] => 10129599 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/129599
Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight Nov 8, 2000 Issued
Array ( [id] => 1287563 [patent_doc_number] => 06639123 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight' [patent_app_type] => B1 [patent_app_number] => 09/709066 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 46 [patent_no_of_words] => 22696 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/639/06639123.pdf [firstpage_image] =>[orig_patent_app_number] => 09709066 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/709066
Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight Nov 8, 2000 Issued
Array ( [id] => 3716 [patent_doc_number] => 07811557 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-10-12 [patent_title] => 'Methods for improving central nervous system functioning' [patent_app_type] => utility [patent_app_number] => 09/698893 [patent_app_country] => US [patent_app_date] => 2000-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 4762 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811557.pdf [firstpage_image] =>[orig_patent_app_number] => 09698893 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/698893
Methods for improving central nervous system functioning Oct 26, 2000 Issued
09/693043 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain Oct 19, 2000 Abandoned
Array ( [id] => 397365 [patent_doc_number] => 07294333 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-11-13 [patent_title] => 'Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues' [patent_app_type] => utility [patent_app_number] => 09/691889 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 31 [patent_no_of_words] => 12438 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/294/07294333.pdf [firstpage_image] =>[orig_patent_app_number] => 09691889 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/691889
Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues Oct 19, 2000 Issued
Menu